Chapter 22. Assessment of Mitochondrial Dysfunction by Microscopy

  1. James A. Dykens4,
  2. Yvonne Will5
  1. Ingrid Pruimboom-Brees1,†,
  2. Germaine Boucher2,
  3. Amy Jakowski2,
  4. Jeanne Wolfgang2

Published Online: 22 JAN 2008

DOI: 10.1002/9780470372531.ch22

Book Title

Drug-Induced Mitochondrial Dysfunction

Drug-Induced Mitochondrial Dysfunction

Additional Information

How to Cite

Pruimboom-Brees, I., Boucher, G., Jakowski, A. and Wolfgang, J. (2008) Assessment of Mitochondrial Dysfunction by Microscopy, in Drug-Induced Mitochondrial Dysfunction (eds J. A. Dykens and Y. Will), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470372531.ch22

Editor Information

  1. 4

    Pfizer, Inc., Sandwich, UK

  2. 5

    Pfizer, Inc., Groton, Connecticut, USA

Author Information

  1. 1

    Drug Safety, GlaxoSmithKline, Ware, Hertfordshire, UK

  2. 2

    Drug Safety R&D, Pfizer, Inc., Groton, Connecticut, USA

  1. †

    Pfizer, Inc., Sandwich, UK

Publication History

  1. Published Online: 22 JAN 2008
  2. Published Print: 14 SEP 2008

ISBN Information

Print ISBN: 9780470111314

Online ISBN: 9780470372531

SEARCH

CHAPTER TOOLS

Get PDF (17768K)

Keywords:

  • mitochondrial dysfunction assessment using microscopy;
  • mitochondriopathies;
  • mitochondrial DNA mutations and diseases

Summary

This chapter contains sections titled:

  • Introduction

  • Mitochondria and cell death

  • Mitochondriopathies

  • Conclusions

  • References

Get PDF (17768K)